Inhibition of c-Met as a Therapeutic Strategy for Esophageal Adenocarcinoma
Open Access
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsNew England Journal of Medicine, 2005
- RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and SurvivalCancer Research, 2004
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- Tumour-cell invasion and migration: diversity and escape mechanismsNature Reviews Cancer, 2003
- The Semaphorin 4D receptor controls invasive growth by coupling with MetNature Cell Biology, 2002
- Constitutive activation of met kinase in non‐small‐cell lung carcinomas correlates with anchorage‐independent cell survivalJournal of Cellular Biochemistry, 2002
- The Multisubstrate Adapter Gab1 Regulates Hepatocyte Growth Factor (Scatter Factor)–c-Met Signaling for Cell Survival and DNA RepairMolecular and Cellular Biology, 2001
- Overexpression of theMET/HGF receptor in ovarian cancerInternational Journal of Cancer, 1994